These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 25316793)

  • 1. LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.
    Rothaug M; Zunke F; Mazzulli JR; Schweizer M; Altmeppen H; Lüllmann-Rauch R; Kallemeijn WW; Gaspar P; Aerts JM; Glatzel M; Saftig P; Krainc D; Schwake M; Blanz J
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15573-8. PubMed ID: 25316793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC; Krainc D
    Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2.
    Zunke F; Andresen L; Wesseler S; Groth J; Arnold P; Rothaug M; Mazzulli JR; Krainc D; Blanz J; Saftig P; Schwake M
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3791-6. PubMed ID: 27001828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase.
    Blanz J; Groth J; Zachos C; Wehling C; Saftig P; Schwake M
    Hum Mol Genet; 2010 Feb; 19(4):563-72. PubMed ID: 19933215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.
    Magalhaes J; Gegg ME; Migdalska-Richards A; Doherty MK; Whitfield PD; Schapira AH
    Hum Mol Genet; 2016 Aug; 25(16):3432-3445. PubMed ID: 27378698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.
    Gonzalez A; Valeiras M; Sidransky E; Tayebi N
    Mol Genet Metab; 2014 Feb; 111(2):84-91. PubMed ID: 24389070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
    Reczek D; Schwake M; Schröder J; Hughes H; Blanz J; Jin X; Brondyk W; Van Patten S; Edmunds T; Saftig P
    Cell; 2007 Nov; 131(4):770-83. PubMed ID: 18022370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose 6-phosphate-independent Lysosomal Sorting of LIMP-2.
    Blanz J; Zunke F; Markmann S; Damme M; Braulke T; Saftig P; Schwake M
    Traffic; 2015 Oct; 16(10):1127-36. PubMed ID: 26219725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
    Mazzulli JR; Xu YH; Sun Y; Knight AL; McLean PJ; Caldwell GA; Sidransky E; Grabowski GA; Krainc D
    Cell; 2011 Jul; 146(1):37-52. PubMed ID: 21700325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.
    Jinn S; Drolet RE; Cramer PE; Wong AH; Toolan DM; Gretzula CA; Voleti B; Vassileva G; Disa J; Tadin-Strapps M; Stone DJ
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2389-2394. PubMed ID: 28193887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
    Dermentzaki G; Dimitriou E; Xilouri M; Michelakakis H; Stefanis L
    PLoS One; 2013; 8(4):e60674. PubMed ID: 23580063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of LIMP-2 in the intracellular trafficking of β-glucosidase in different human cellular models.
    Malini E; Zampieri S; Deganuto M; Romanello M; Sechi A; Bembi B; Dardis A
    FASEB J; 2015 Sep; 29(9):3839-52. PubMed ID: 26018676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
    Rocha EM; Smith GA; Park E; Cao H; Graham AR; Brown E; McLean JR; Hayes MA; Beagan J; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Antioxid Redox Signal; 2015 Aug; 23(6):550-64. PubMed ID: 26094487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases.
    Liou B; Haffey WD; Greis KD; Grabowski GA
    J Biol Chem; 2014 Oct; 289(43):30063-74. PubMed ID: 25202012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal integral membrane protein 2 (LIMP-2) restricts the invasion of Trypanosoma cruzi extracellular amastigotes through the activity of the lysosomal enzyme β-glucocerebrosidase.
    Gonçalves VM; D'Almeida V; Müller KB; Real F; Mortara RA
    Microbes Infect; 2014 Mar; 16(3):253-60. PubMed ID: 24269705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.